A box of Plaquenil, an anti-malaria drug hydroxychloroquine made by Sanofi, used for years to treat malaria and autoimmune disorders.
Donald Trump
The study, the first randomized, placebo-controlled trial, which is considered the "gold standard" in science, looked at 821 people in the United States and Canada who had been exposed to the coronavirus. About 12% of the people who were given the malaria drug developed Covid-19, compared to 14% who did not receive the drug, according to the study's findings.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
No Evidence Hydroxychloroquine Is Helpful In Preventing COVID-19, Study FindsA study of more than 800 health workers, first responders and others finds that taking hydroxychloroquine to prevent COVID-19 is no better than a placebo in preventing the illness.
Weiterlesen »
Hydroxychloroquine fails to prevent coronavirus: study in NEJM - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »
Trump said he took hydroxychloroquine to prevent coronavirus, but new study shows that doesn't workOn the heels of studies showing hydroxychloroquine doesn't help patients in the hospital with Covid-19, a new study -- the first of its kind -- shows the drug doesn't work to prevent infection with the virus, either.
Weiterlesen »
Trump had no side effects after taking hydroxychloroquine, White House doctor saysTrump revealed last month he was taking hydroxychloroquine to protect himself from contracting the coronavirus.
Weiterlesen »
World Health Organization resumes coronavirus trial on malaria drug hydroxychloroquine after examining safety concerns
Weiterlesen »